Thomas J. Cahill

Tom Cahill, MD, PhD, is the founder of Newpath Partners, a venture firm in Boston focusing on life sciences. Newpath translates scientific discoveries into patient treatments, creating companies from the ground up. Cahill collaborates with entrepreneurial scientists, aligning interests across the board. He’s a director at several innovative companies, including Chroma Medicine and Exo Therapeutics, and contributes to non-profits like STSC-19 and pgEd. Cahill earned his MD and PhD from Duke University, marking him as a key player in healthcare innovation and venture capital.